Latest filings (excl ownership)
8-K
BullFrog AI’s CSO, Tom Chittenden, to Present at the Quantum Computing Symposium at Bio-IT World Conference & Expo
9 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
BullFrog AI Announces Availability of Fireside Chat Recording Featuring CEOs of BullFrog AI and the Lieber Institute
8 Mar 24
8-K
BullFrog AI Appoints Globally Renowned Biomedical AI Expert Dr. Thomas W. Chittenden as Chief Scientific Officer
26 Feb 24
8-K
BullFrog AI to Discuss Findings from its Collaboration with Lieber Institute for Brain Development in Fireside Chat Hosted by RedChip
9 Feb 24
8-K
Bullfrog AI Announces Pricing of $5.7 Million Public Offering
6 Feb 24
424B3
Prospectus supplement
2 Feb 24
EFFECT
Notice of effectiveness
1 Feb 24
S-1
IPO registration
29 Jan 24
CORRESP
Correspondence with SEC
29 Jan 24
CORRESP
Correspondence with SEC
29 Jan 24
CORRESP
Correspondence with SEC
29 Jan 24
8-K
BullFrog AI Strengthens Scientific Advisory Board with the Addition of Dr. Gwenn Smith and Dr. Jeremiah Wala
26 Jan 24
UPLOAD
Letter from SEC
24 Jan 24
DRS
Draft registration statement
19 Jan 24
8-K
Regulation FD Disclosure
17 Jan 24
8-K
BullFrog AI Announces Issuance of Australian Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
16 Jan 24
8-K
BullFrog AI Issues Letter to Shareholders
29 Dec 23
10-Q
2023 Q3
Quarterly report
14 Nov 23
8-K
Entry into a Material Definitive Agreement
20 Oct 23
8-K
BullFrog AI Announces Identification of Novel Potential Drug Targets for Colorectal Cancer Using Its AI-Driven bfLEAP™ Platform
5 Oct 23
8-K
BullFrog AI Announces Positive Data from Preclinical Study Evaluating Novel Prodrug of Mebendazole for Treatment of Glioblastoma
26 Sep 23
8-K
BullFrog AI Announces Launch of BullFrog Data Networks™, a Data Insights Tool Powered by the bfLEAP™ Platform
20 Sep 23
8-K
BullFrog AI Announces Three - Year Global Strategic Partnership with 35 W. 35th Street, 11th Floor | New York, NY 10001 | 212 827 0020 | www.tiberend.com
14 Sep 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
8-K
BullFrog AI Announces Issuance of U.S. Patent Protecting Novel Prodrugs of Mebendazole and Their Use in Treating Cancer
25 Jul 23
8-K
BullFrog AI Announces Appointment of Enrique García-Rivera as Vice President of Artificial Intelligence
11 Jul 23
S-8
Registration of securities for employees
3 Jul 23
8-K
BullFrog AI CEO Vin Singh to Present at the Gujarati Physicians Convention 2023
9 Jun 23
8-K
BullFrog AI Strengthens Capabilities of its AI Platform through Expansion of Licensing Agreement with Johns Hopkins Applied Physics Laboratory
5 Jun 23
8-K
BullFrog AI Files Quarterly Report on Form 10-Q
26 May 23
10-Q
2023 Q1
Quarterly report
24 May 23
NT 10-Q
Notice of late quarterly filing
16 May 23
8-K
BullFrog AI Files 2022 Annual Report on Form 10-K
25 Apr 23
10-K
2022 FY
Annual report
25 Apr 23
NT 10-K
Notice of late annual filing
3 Apr 23
8-K
Entry into a Material Definitive Agreement
21 Feb 23
424B4
Prospectus supplement with pricing info
16 Feb 23
CERT
Certification of approval for exchange listing
14 Feb 23
S-1/A
IPO registration (amended)
13 Feb 23
Latest ownership filings
4
Vininder Singh
3 Apr 24
144
Notice of proposed sale of securities
3 Apr 24
144
Notice of proposed sale of securities
23 Jan 24
4
Vininder Singh
22 Jan 24
4
Vininder Singh
22 Jan 24
4
DANE R SAGLIO
22 Jan 24
4
Vininder Singh
18 Jan 24
4
Vininder Singh
12 Jan 24
4
Vininder Singh
9 Jan 24
4
Vininder Singh
5 Jan 24
144
Notice of proposed sale of securities
2 Jan 24
4
Vininder Singh
7 Sep 23
4
William Enright
15 Jun 23
4
William Enright
9 May 23
3
William Enright
9 May 23
4
Jason David Hanson
9 May 23
3
Jason David Hanson
9 May 23
4/A
R Don Elsey
9 May 23
4
R Don Elsey
18 Apr 23
3
R Don Elsey
18 Apr 23
4
DANE R SAGLIO
22 Mar 23
3
DANE R SAGLIO
3 Mar 23
3
Vininder Singh
3 Mar 23